Track Systemic Inflammatory Calming & Resolution During BPC-157 Protocols
BPC-157 is a pentadecapeptide studied in preclinical models for gut healing, tendon repair, and anti-inflammatory signaling. The Inflammation Compass™ evaluates how your protocol shapes systemic biology — tracking downstream systemic inflammatory calming and active resolution signaling at the gene expression level.
Understanding BPC-157
Body Protection Compound-157 — a pentadecapeptide consisting of 15 amino acids, originally isolated from human gastric juice. It has become one of the most widely discussed peptides in regenerative medicine research.
What Makes BPC-157 Unique
BPC-157 is derived from a naturally occurring protective protein found in human gastric juice. Unlike synthetic compounds, it's a fragment of a protein your body already produces. Its stability in gastric acid and broad tissue affinity distinguish it from most other peptides under investigation.
How It Works
BPC-157 acts through multiple molecular pathways — upregulating VEGF (vascular endothelial growth factor) for angiogenesis, modulating the nitric oxide system, activating the FAK-paxillin pathway for cell migration, and interacting with growth hormone receptors. This multi-pathway mechanism is what makes monitoring so valuable.
Common Research Applications
In research and clinical settings, BPC-157 is studied for gut healing and mucosal protection, tendon and ligament repair, joint recovery, neuroprotection (dopaminergic and serotonergic systems), and broad anti-inflammatory effects across multiple tissue types.
Multi-System Preclinical Profile
What sets BPC-157 apart in preclinical research is the breadth of biological systems it interfaces with — from local angiogenic signaling and collagen synthesis to neuroprotective cascades. While localized tissue histology cannot be measured from blood, whole-blood transcriptomic profiling evaluates how these multi-pathway effects register systemically — specifically through inflammatory cytokine calming, oxidative balance, and active resolution signaling.
Important Note
BPC-157 is a research peptide. It is not FDA-approved for any therapeutic use. Biomeme Labs does not endorse, prescribe, or advocate the use of BPC-157. The information on this page is provided for educational purposes to explain the biological pathways that transcriptomic monitoring can assess.
Preclinical Mechanisms in the Literature
Published cellular and animal studies investigate BPC-157 across specific repair signaling axes. While local tissue repair occurs at the injury site, the Inflammation Compass™ evaluates overall systemic inflammatory calming, oxidative balance, and active resolution capacity in whole blood across the 3 Health Domains.
Angiogenic Signaling
VEGF Pathway · Endothelial Recruitment
Biological role: Angiogenesis is the formation of new blood vessels from
existing vasculature — essential for delivering oxygen and nutrients to damaged
tissue. BPC-157 has been shown to upregulate vascular endothelial growth factor (VEGF) and its
receptors in preclinical models.
Systemic connection: In whole blood, circulating leukocyte vascular signaling reflects systemic support for microvascular recruitment and endothelial repair without requiring invasive tissue biopsies.
Anti-Inflammatory Modulation
TNF-α · IL-6 · IL-1β · Myeloid Calming
Biological role: Chronic or excessive inflammation impairs healing.
BPC-157 modulates key pro-inflammatory cytokines in animal studies — suppressing excessive TNF-α, IL-6,
and IL-1β while facilitating the transition toward active biological resolution.
Systemic connection: Downregulation of inflammatory cytokine programs in circulating leukocytes is directly measured by the Activation domain, signaling that systemic inflammatory tone is settling.
Collagen & Structural Remodeling
Preclinical Model: Tendon · FAK-Paxillin
Biological role: Preclinical studies show BPC-157 promotes type I and type III collagen synthesis in connective tissues and activates the focal adhesion kinase (FAK)-paxillin pathway for fibroblast migration.
Systemic connection: While tendon collagen synthesis (COL1A1/COL3A1) occurs locally at the injury site, circulating immune cells reflect the systemic biological quietude necessary for unhindered connective tissue remodeling.
Nitric Oxide Homeostasis
eNOS · iNOS · Endothelial Modulation
Biological role: BPC-157 interacts with the nitric oxide (NO) system — modulating both endothelial NOS (eNOS) and inducible NOS (iNOS) to balance protective versus inflammatory nitro-oxidative signaling.
Systemic connection: In whole blood, balanced leukocyte oxidative homeostasis reflects whether the systemic vascular and immune environment is calm or undergoing oxidative strain.
Neuro-Immune Signaling
Preclinical Model: Gut-Brain Axis · Neurotrophic Support
Biological role: Preclinical research explores BPC-157's neuroprotective interactions along the gut-brain axis, including monoaminergic system modulation and neurotrophic factor support.
Systemic connection: While central nervous tissue is sequestered behind the blood-brain barrier, circulating leukocytes capture systemic neuro-immune communication and whole-body inflammatory tone.
Diagnostic Boundary: The Inflammation Compass™ is a whole-blood RNA sequencing test performed by Biomeme Labs. It measures systemic inflammatory and resolution programs across the 3 Health Domains (Activation, Antiviral Response, Resolution) plus cellular deconvolution. It does not measure localized tendon collagen synthesis (COL1A1/COL3A1), local wound histology, or central nervous system neurotransmitter receptors directly.
Why Standard Labs Fall Short
Standard blood panels were not designed to detect peptide response. Here's what traditional tests miss — and what the Inflammation Compass™ captures in circulating leukocytes.
Standard Blood Panels
- Cannot assess early leukocyte transcriptional shifts or active resolution programs
- Standard hs-CRP is a delayed hepatic marker — misses early leukocyte gene activation
- CBC only counts cell types — cannot measure transcriptional activation state
- Completely blind to active biological resolution and stand-down machinery
- Cannot distinguish true gene expression regulation from shifts in circulating immune cell counts
The Inflammation Compass™
- Measures systemic inflammatory calming across cytokine and danger-sensing pathways (Activation)
- Quantifies active cellular stand-down and apoptotic clearance programs (Resolution)
- Evaluates baseline interferon defense signatures (Antiviral Response)
- Provides computational cellular deconvolution to distinguish cell population shifts from transcriptional changes
Track Your BPC-157 Response
The Inflammation Compass™ is designed to visualize how peptide protocols interface with systemic biology — showing whether inflammatory programs are calming, active resolution machinery is engaging, and how your molecular profile changes over time.
Dashboard Coming Soon
We're building a dashboard experience that lets you visualize how BPC-157 protocols interface with systemic physiology — inflammatory cytokine calming, oxidative balance, active resolution signaling, and cellular deconvolution — all in one place. Track changes across time points to see how your systemic biological response evolves.
Activation
Cytokine & danger programs
Resolution
Stand-down & clearance
Immune Census
Cellular deconvolution
The Inflammation Compass™ measures downstream systemic inflammatory calming and active resolution signaling in circulating leukocytes for individuals on BPC-157 protocols today.
Track Downstream Systemic Calming & Resolution
With the Inflammation Compass™
Quantify systemic inflammatory calming, oxidative balance, and active resolution signaling in circulating blood. Baseline package ($600) covers 2 complete tests with at-home mobile phlebotomy included.